MedyMatch Technology
Developer of AI-driven clinical decision support for acute medical imaging. The company applies deep learning and machine vision to 3D imaging and patient-specific data to assist emergency-room triage and detect intracranial hemorrhage. Offers a cloud-based platform designed for integration with hospital workflows and third-party imaging platforms, and collaborates with clinical partners for validation and deployment.
Industries
Nr. of Employees
small (1-50)
MedyMatch Technology
Israel Office: 76 Yigal Alon Street, 5th Floor, Tel Aviv, Israel 67067
Products
Intracranial hemorrhage detection (AI-assisted imaging analysis)
An AI application that analyzes CT brain images to detect intracranial bleeding and provide actionable alerts to clinicians for acute triage.
Intracranial hemorrhage detection (AI-assisted imaging analysis)
An AI application that analyzes CT brain images to detect intracranial bleeding and provide actionable alerts to clinicians for acute triage.
Services
Deployment and integration of cloud-hosted AI models into hospital workflows and imaging pipelines to provide near-real-time diagnostic assistance.
Technical and commercial partnerships to integrate AI analytics into imaging devices and mobile/pre-hospital systems.
Deployment and integration of cloud-hosted AI models into hospital workflows and imaging pipelines to provide near-real-time diagnostic assistance.
Technical and commercial partnerships to integrate AI analytics into imaging devices and mobile/pre-hospital systems.
Expertise Areas
- AI for medical imaging
- Clinical decision support in emergency medicine
- Deep learning and computer vision
- Pre-hospital imaging and telestroke deployment
Key Technologies
- Deep learning
- Machine vision / computer vision
- 3D medical imaging analysis
- Cloud-based analytics
News & Updates
Participation in an industry event focusing on digital health innovation (Berlin).
Announcement of a strategic alliance to distribute AI imaging tools for pre-hospital and mobile use.
Announcement that the company's imaging analytics would be integrated into a third-party cognitive imaging offering to help identify head trauma and stroke.
Received Breakthrough Device designation from the U.S. Food and Drug Administration to accelerate market access for an intracranial hemorrhage software application.
Multiple media and industry reports covering the company's AI platform and partnerships, including coverage of technology launch and strategic alliances.
Participation in an industry event focusing on digital health innovation (Berlin).
Announcement of a strategic alliance to distribute AI imaging tools for pre-hospital and mobile use.
Announcement that the company's imaging analytics would be integrated into a third-party cognitive imaging offering to help identify head trauma and stroke.
Received Breakthrough Device designation from the U.S. Food and Drug Administration to accelerate market access for an intracranial hemorrhage software application.
Multiple media and industry reports covering the company's AI platform and partnerships, including coverage of technology launch and strategic alliances.